MedTrace Logo

Acute Unilateral Vestibulopathy and Corticosteroid Treatment

NCT02912182 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2021-09-10

No results posted yet for this study

Summary

Randomized placebo controlled trial on patients suffering from acute unilateral vestibulopathy. Patients will be randomized into 3 arms; 1) Placebo only, 2) Short corticosteroid treatment (3days) 3) Longer corticosteroid treatment (11 days).

Vestibular function as well as subjective symptoms will be estimated in the acute stage and regularly up to one year after the debut.

Conditions

  • Vestibular Diseases
  • Vestibular Neuronitis

Interventions

DRUG

Betamethasone

Betamethasone intravenous

DRUG

Placebo

Placebo intravenous NaCl intravenous administration Placebo tablets

DRUG

Prednisolone

Oral tablets

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Fredrik Tjernström, MD, PhD · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02912182 on ClinicalTrials.gov